Annual report pursuant to Section 13 and 15(d)


Cover - USD ($)
12 Months Ended
Aug. 31, 2023
Nov. 20, 2023
Feb. 28, 2023
Cover [Abstract]      
Entity Registrant Name Lexaria Bioscience Corp    
Entity Central Index Key 0001348362    
Document Type 10-K    
Amendment Flag false    
Entity Voluntary Filers No    
Current Fiscal Year End Date --08-31    
Entity Well Known Seasoned Issuer No    
Entity Small Business true    
Entity Shell Company false    
Entity Emerging Growth Company false    
Entity Current Reporting Status Yes    
Document Period End Date Aug. 31, 2023    
Entity Filer Category Non-accelerated Filer    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Entity Common Stock Shares Outstanding   10,276,641  
Entity Public Float     $ 16.2
Document Annual Report true    
Document Transition Report false    
Document Fin Stmt Error Correction Flag false    
Entity File Number 000-52138    
Entity Incorporation State Country Code NV    
Entity Tax Identification Number 20-2000871    
Entity Address Address Line 1 #100 – 740 McCurdy Road    
Entity Address City Or Town Kelowna    
Entity Address Country CA    
Entity Address Postal Zip Code V1X 2P7    
City Area Code 250    
Auditor Name MaloneBailey, LLP    
Auditor Location Houston, Texas    
Auditor Firm Id 206    
Local Phone Number 765-6424    
Security 12b Title Common Stock, Par Value $0.001    
Trading Symbol LEXX    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes